Systemic Treatment of Psoriasis with JAK Inhibitors: A Review.

Volume: 10, Issue: 1, Pages: 29 - 42
Published: Feb 1, 2020
Abstract
Psoriasis is a prevalent chronic inflammatory disease. The inflammatory response is driven by T cells and mediated by multiple cytokines such as tumor necrosis factor and the interleukins IL-17 and IL-23. Moderate-to-severe psoriasis is treated systemically, using either biologics or conventional treatments with small-molecule drugs. The newer biologics are very effective and well tolerated, but not all patients respond to treatment with...
Paper Details
Title
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review.
Published Date
Feb 1, 2020
Volume
10
Issue
1
Pages
29 - 42
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.